Targeting CDK4 and CDK6: From Discovery to Therapy von Sherr, Charles J, Beach, David, Shapiro, Geoffrey I

Volltext

Principles of Tumor Suppression von Sherr, Charles J

Volltext

The pezcoller lecture : Cancer cell cycles revisited von SHERR, C. J

Volltext

NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination von Ruscetti, Marcus, Leibold, Josef, Bott, Matthew J, Fennell, Myles, Kulick, Amanda, Salgado, Nelson R, Chen, Chi-Chao, Ho, Yu-Jui, Sanchez-Rivera, Francisco J, Feucht, Judith, Baslan, Timour, Tian, Sha, Chen, Hsuan-An, Romesser, Paul B, Poirier, John T, Rudin, Charles M, de Stanchina, Elisa, Manchado, Eusebio, Sherr, Charles J, Lowe, Scott W

Volltext

Cancer Cell Cycles von Sherr, Charles J.

Volltext

The RB and p53 pathways in cancer von Sherr, Charles J, McCormick, Frank

Volltext

Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23 von Bertwistle, David, Sugimoto, Masataka, Sherr, Charles J.

Volltext

The INK4a/ARF network in tumour suppression von Sherr, Charles J.

Volltext

CDK inhibitors: positive and negative regulators of G1-phase progression von Sherr, C J, Roberts, J M

Volltext

CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma von Huang, Chun-Hao, Lujambio, Amaia, Zuber, Johannes, Tschaharganeh, Darjus F, Doran, Michael G, Evans, Michael J, Kitzing, Thomas, Zhu, Nan, de Stanchina, Elisa, Sawyers, Charles L, Armstrong, Scott A, Lewis, Jason S, Sherr, Charles J, Lowe, Scott W

Volltext

Tumor suppression by Ink4a–Arf: progress and puzzles von Lowe, Scott W, Sherr, Charles J

Volltext

Living with or without cyclins and cyclin-dependent kinases von Sherr, Charles J, Roberts, James M

Volltext

Forging a signature of in vivo senescence von Sharpless, Norman E., Sherr, Charles J.

Volltext

Cell Cycle-Targeted Cancer Therapies von Sherr, Charles J, Bartek, Jiri

Volltext

Divorcing ARF and p53: an unsettled case von Sherr, Charles J.

Volltext

Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia von Williams, Richard T, den Besten, Willem, Sherr, Charles J

Volltext

Arf Gene Loss Enhances Oncogenicity and Limits Imatinib Response in Mouse Models of Bcr-Abl-Induced Acute Lymphoblastic Leukemia von Williams, Richard T., Roussel, Martine F., Sherr, Charles J.

Volltext

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis von Eischen, C M, Weber, J D, Roussel, M F, Sherr, C J, Cleveland, J L

Volltext

Tumor surveillance via the ARF-p53 pathway von Sherr, C J

Volltext

The ARF/p53 pathway von Sherr, Charles J, Weber, Jason D

Volltext